EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 D

Ensembl ID : ENSCVAG00000001734
Gene Symbol: CACNA1D
4 Cross references
210 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 E

Ensembl ID : ENSCVAG00000022828
Gene Symbol: CACNA1E
3 Cross references
215 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 S

Ensembl ID : ENSCVAG00000022296
Gene Symbol: CACNA1S
3 Cross references
196 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSCVAG00000002922
Gene Symbol: CNR1
3 Cross references
154 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSCVAG00000020316
Gene Symbol: CNR1
4 Cross references
135 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSCVAG00000018091
Gene Symbol: CNR2
1 Cross references
196 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSCVAG00000015085
Gene Symbol: CA12
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 14

Ensembl ID : ENSCVAG00000009348
Gene Symbol: CA14
3 Cross references
211 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSCVAG00000018065
Gene Symbol: LOC107090005
3 Cross references
198 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSCVAG00000014028
Gene Symbol: LOC107090331
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSCVAG00000013709
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSCVAG00000006488
Gene Symbol: CA6
3 Cross references
227 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).